These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 2164644

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Multicenter clinical study of the antihypertensive activity of lisinopril].
    Cinotti GA, Bossini A, Cagli V, Corea L, Di Veroli C, Morabito S, Pierucci A, Porcellati C, Savino K, Timio M.
    Minerva Med; 1989 Jan; 80(1):53-63. PubMed ID: 2536907
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
    Borghi C, Cosentino E, De Sanctis D.
    Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A new angiotensin-converting enzyme inhibitor: treatment of hypertension and congestive heart failure. Proceedings of an international symposium on enalapril, sponsored by Merck Sharp & Dohme International, São Paulo, Brazil, November 10, 1984.
    Drugs; 1985 Dec; 30 Suppl 1():1-96. PubMed ID: 2994983
    [No Abstract] [Full Text] [Related]

  • 31. Evolution of angiotensin-converting enzyme inhibitors.
    Wyvratt MJ.
    Clin Physiol Biochem; 1988 Dec; 6(3-4):217-29. PubMed ID: 2849521
    [Abstract] [Full Text] [Related]

  • 32. Increase in vasoactive intestinal polypeptides (VIP) by the angiotensin converting enzyme (ACE) inhibitor lisinopril in congestive heart failure. Relation to haemodynamic and hormonal changes.
    Woie L, Dickstein K, Kaada B.
    Gen Pharmacol; 1987 Dec; 18(6):577-87. PubMed ID: 2822521
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Optimizing the use of ACE inhibitors in patients with congestive heart failure.
    Tsikouris JP.
    Conn Med; 1999 Feb; 63(2):91-3. PubMed ID: 10188339
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. ACE inhibitors in mild to moderate hypertension: comparison of lisinopril and captopril administered once daily. French Cooperative Study Group.
    Gosse P, Dallocchio M, Gourgon R.
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():23-8. PubMed ID: 2550642
    [Abstract] [Full Text] [Related]

  • 40. Effects of subchronic treatment with trandolapril and enalapril on cardiovascular morphologic alterations in the aged spontaneously hypertensive rat with heart failure.
    Secchi J, Lecaque D, Dunn FW, Jouquey S, Auberval UD, Benzoni F, Sirugue O, Hamon G.
    J Cardiovasc Pharmacol; 1994 Jun; 23 Suppl 4():S30-7. PubMed ID: 7527099
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.